Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven Langston, Xiaofeng Yang, Neil Bence et al.|Journal of Medicinal Chemistry|2021Cited by 205